We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teva Pharmaceutical’s multiple sclerosis drug Copaxone achieved $1.18 billion in sales in 2005, making it Teva’s first blockbuster drug, according to the firm best known as a generic-drug powerhouse.